Zai Lab (ZLAB) director receives 22,371 ADS restricted share grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
WIRTH PETER reported acquisition or exercise transactions in this Form 4 filing.
Zai Lab Ltd director Peter Wirth received a grant of 22,371 American Depositary Shares (ADSs) as a stock award. The filing notes these are restricted shares that vest in full on June 17, 2027, if he continues serving on the board. After this grant, he directly holds 416,121 ADSs. Each ADS represents ten ordinary shares, and the award was made at no cash purchase price, reflecting equity-based director compensation rather than an open-market share purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
WIRTH PETER
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | American Depositary Shares | 22,371 | $0.00 | -- |
Holdings After Transaction:
American Depositary Shares — 416,121 shares (Direct, null)
Footnotes (1)
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Represents restricted shares that vest in full on June 17, 2027, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date.
Key Figures
Restricted ADS grant: 22,371 ADSs
Holdings after grant: 416,121 ADSs
Vesting date: June 17, 2027
+1 more
4 metrics
Restricted ADS grant
22,371 ADSs
Stock award to director on June 17, 2026
Holdings after grant
416,121 ADSs
Director’s direct ownership following the transaction
Vesting date
June 17, 2027
Restricted shares vest if board service continues
ADS to ordinary share ratio
1 ADS = 10 ordinary shares
Equivalence between ADSs and ordinary shares
Key Terms
American Depositary Shares, restricted shares, vest, board of directors, +1 more
5 terms
vest financial
"restricted shares that vest in full on June 17, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
board of directors financial
"subject to the Reporting Person's continued service as a member of the issuer's board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
fungible financial
"Our ADSs and Ordinary Shares are fully fungible."
Fungible describes an asset that is interchangeable with another of the same kind because each unit holds the same value and function. For investors this matters because fungible assets are easier to trade, price, and store—think of cash or grains where one unit can replace another, unlike a unique artwork or a signed collectible which may be worth more or less depending on provenance. Fungibility affects liquidity, market efficiency, and how assets are settled or regulated.
FAQ
What did Zai Lab (ZLAB) director Peter Wirth report in this Form 4?
Peter Wirth reported receiving a grant of 22,371 American Depositary Shares from Zai Lab. The award is a stock-based grant with no cash purchase price and reflects equity compensation for his role on the company’s board of directors.
How many Zai Lab (ZLAB) ADSs does Peter Wirth hold after this grant?
After the reported grant, Peter Wirth directly holds 416,121 American Depositary Shares of Zai Lab. This total includes the newly awarded 22,371 ADSs and represents his direct ownership position following the June 17, 2026 equity grant.
Was Peter Wirth’s Zai Lab (ZLAB) transaction an open-market purchase or a grant?
The transaction was a grant of restricted shares, not an open-market purchase. It is coded as a grant or award acquisition with a price of $0.0000 per ADS, indicating stock-based compensation tied to his board service rather than a discretionary market buy.